4//SEC Filing
ARATANA THERAPEUTICS, INC. 4
Accession 0001209191-17-006464
CIK 0001509190operating
Filed
Jan 30, 7:00 PM ET
Accepted
Jan 31, 6:03 PM ET
Size
6.4 KB
Accession
0001209191-17-006464
Insider Transaction Report
Form 4
St Peter Steven
DirectorPRESIDENT AND CEO
Transactions
- Sale
Common Stock
2017-01-27$7.72/sh−50,000$385,875→ 632,693 total
Holdings
- 86,997(indirect: By LLC)
Common Stock
Footnotes (3)
- [F1]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.70 to $7.87, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F3]Held in the name of Vie Venture LLC, a Delaware limited liability company ("Vie Venture"). The Reporting Person has sole voting and dispositive power over the shares held by Vie Venture, but disclaims beneficial ownership of the shares held thereby except to the extent of his pecuniary interest therein.
Documents
Issuer
ARATANA THERAPEUTICS, INC.
CIK 0001509190
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001509190
Filing Metadata
- Form type
- 4
- Filed
- Jan 30, 7:00 PM ET
- Accepted
- Jan 31, 6:03 PM ET
- Size
- 6.4 KB